LOS ANGELES—Looking to tap into the world’s biggest biotech center, biomedical development company Genesis Bioventures, Inc. (GBI) announced it has opened its new corporate headquarters in Los Angeles, just down the highway from its former location in Vancouver. The move is part of a restructuring and reorganization that the company announced in 2005.

“The office location we selected is in the heart of one of California's top finance, business, research, and technology centers, and gives us immediate high-level access to key business, commercial and science resources that we intend to fully utilize to grow our company,” said Douglas Lane, GBI CEO and chairman.

 

With the restructuring completed, the company is looking to enter a significant growth phase and is opening its doors to potential partners that will facilitate the achievement of its commercial objectives.